Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Later this week, The George Institute for Global Health and the Entrepreneurship Centre will be hosting Big Change: Sustainable Healthcare for the 21st Century, a significant international event that will address the issues and challenges facing healthcare this century.

This meeting will involve selected group of high-profile politicians, academics, entrepreneurs, investors and journalists in an interactive programme of challenge and debate.

The healthcare challenge facing humanity is unprecedented. Current systems are not sustainable and the world requires a fundamentally different way to deliver healthcare to all who need it. All around the globe healthcare systems are struggling to meet the demands of growing and ageing populations that have high expectations of the healthcare they want to receive. This is particularly true in the developed world, but it is also evident in emerging markets such as India and China. These economies have created new middle class populations that have contributed to dramatic rises in the prevalence of non-communicable disease such as cancers, heart disease and diabetes. Not only that, but the poor still suffer from disease associated with poverty such as malaria, TB and HIV.

Big Change: Sustainable Healthcare for the 21st century takes place on the 22 and 23 November 2013, at the Saïd Business School.

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.